Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease.


Journal

Nature genetics
ISSN: 1546-1718
Titre abrégé: Nat Genet
Pays: United States
ID NLM: 9216904

Informations de publication

Date de publication:
04 2022
Historique:
received: 12 02 2021
accepted: 17 12 2021
pubmed: 5 3 2022
medline: 15 4 2022
entrez: 4 3 2022
Statut: ppublish

Résumé

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enters human host cells via angiotensin-converting enzyme 2 (ACE2) and causes coronavirus disease 2019 (COVID-19). Here, through a genome-wide association study, we identify a variant (rs190509934, minor allele frequency 0.2-2%) that downregulates ACE2 expression by 37% (P = 2.7 × 10

Identifiants

pubmed: 35241825
doi: 10.1038/s41588-021-01006-7
pii: 10.1038/s41588-021-01006-7
pmc: PMC9005345
doi:

Substances chimiques

Angiotensin-Converting Enzyme 2 EC 3.4.17.23

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

382-392

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001878
Pays : United States

Investigateurs

Gonçalo Abecasis (G)
Michael Cantor (M)
Giovanni Coppola (G)
Andrew Deubler (A)
Aris Economides (A)
Katia Karalis (K)
Luca A Lotta (LA)
Alan Shuldiner (A)
Christina Beechert (C)
Caitlin Forsythe (C)
Erin D Fuller (ED)
Zhenhua Gu (Z)
Michael Lattari (M)
Alexander Lopez (A)
Maria Sotiropoulos Padilla (MS)
Manasi Pradhan (M)
Kia Manoochehri (K)
Thomas D Schleicher (TD)
Louis Widom (L)
Sarah E Wolf (SE)
Ricardo H Ulloa (RH)
Amelia Averitt (A)
Dadong Li (D)
Sameer Malhotra (S)
Jeffrey Staples (J)
Suying Bao (S)
Boris Boutkov (B)
Siying Chen (S)
Gisu Eom (G)
Alicia Hawes (A)
Shareef Khalid (S)
Olga Krasheninina (O)
Rouel Lanche (R)
Evan K Maxwell (EK)
George Mitra (G)
Mona Nafde (M)
Sean O'Keeffe (S)
Max Orelus (M)
Razvan Panea (R)
Tommy Polanco (T)
Ayesha Rasool (A)
Jeffrey G Reid (JG)
William Salerno (W)
Jeffrey C Staples (JC)
Kathie Sun (K)
Jiwen Xin (J)
Joshua Backman (J)
Manuel Allen Revez Ferreira (MAR)
Arkopravo Ghosh (A)
Christopher Gillies (C)
Eric Jorgenson (E)
Hyun Min Kang (HM)
Michael Kessler (M)
Alexander Li (A)
Nan Lin (N)
Daren Liu (D)
Adam Locke (A)
Arden Moscati (A)
Charles Paulding (C)
Carlo Sidore (C)
Bin Ye (B)
Blair Zhang (B)
Andrey Ziyatdinov (A)
Ariane Ayer (A)
Aysegul Guvenek (A)
George Hindy (G)
Jan Freudenberg (J)
Jonas Bovijn (J)
Julie E Horowitz (JE)
Kavita Praveen (K)
Manav Kapoor (M)
Mary Haas (M)
Moeen Riaz (M)
Niek Verweij (N)
Olukayode Sosina (O)
Parsa Akbari (P)
Priyanka Nakka (P)
Sahar Gelfman (S)
Sujit Gokhale (S)
Tanima De (T)
Veera Rajagopal (V)
Gannie Tzoneva (G)
Juan Rodriguez-Flores (J)
Shek Man Chim (SM)
Valerio Donato (V)
Daniel Fernandez (D)
Giusy Della Gatta (GD)
Alessandro Di Gioia (A)
Kristen Howell (K)
Lori Khrimian (L)
Minhee Kim (M)
Hector Martinez (H)
Lawrence Miloscio (L)
Sheilyn Nunez (S)
Elias Pavlopoulos (E)
Trikaldarshi Persaud (T)
Esteban Chen (E)
Marcus B Jones (MB)
Michelle G LeBlanc (MG)
Jason Mighty (J)
Lyndon J Mitnaul (LJ)
Nirupama Nishtala (N)
Nadia Rana (N)

Commentaires et corrections

Type : UpdateOf
Type : CommentIn

Informations de copyright

© 2022. The Author(s).

Références

Yan, R. et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 367, 1444–1448 (2020).
pubmed: 32132184 pmcid: 7164635 doi: 10.1126/science.abb2762
Bai, Y. et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA 323, 1406–1407 (2020).
pubmed: 32083643 pmcid: 7042844 doi: 10.1001/jama.2020.2565
Guan, W.-J. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708–1720 (2020).
pubmed: 32109013 doi: 10.1056/NEJMoa2002032
Kimball, A. et al. Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing facility—King County, Washington, March 2020. MMWR Morb. Mortal. Wkly Rep. 69, 377–381 (2020).
pubmed: 32240128 pmcid: 7119514 doi: 10.15585/mmwr.mm6913e1
Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727–733 (2020).
pubmed: 31978945 pmcid: 7092803 doi: 10.1056/NEJMoa2001017
Atkins, J. L. et al. Preexisting comorbidities predicting COVID-19 and mortality in the UK Biobank community cohort. J. Gerontol. A 75, 2224–2230 (2020).
doi: 10.1093/gerona/glaa183
Cummings, M. J. et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet 395, 1763–1770 (2020).
pubmed: 32442528 pmcid: 7237188 doi: 10.1016/S0140-6736(20)31189-2
Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395, 1054–1062 (2020).
pubmed: 32171076 pmcid: 7270627 doi: 10.1016/S0140-6736(20)30566-3
Ellinghaus, D. et al. Genomewide association study of severe Covid-19 with respiratory failure. N. Engl. J. Med. 383, 1522–1534 (2020).
pubmed: 32558485 doi: 10.1056/NEJMoa2020283
Pairo-Castineira, E. et al. Genetic mechanisms of critical illness in COVID-19. Nature 591, 92–98 (2021).
pubmed: 33307546 doi: 10.1038/s41586-020-03065-y
Shelton, J. F. et al. Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity. Nat. Genet. 53, 801–808 (2021).
pubmed: 33888907 doi: 10.1038/s41588-021-00854-7
Niemi, M. E. K. et al. Mapping the human genetic architecture of COVID-19. Nature 600, 472–477 (2021).
doi: 10.1038/s41586-021-03767-x
van der Made, C. I. et al. Presence of genetic variants among young men with severe COVID-19. JAMA 324, 663–673 (2020).
pubmed: 32706371 doi: 10.1001/jama.2020.13719
Zhang, Q. et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 370, eabd4570 (2020).
pubmed: 32972995 pmcid: 7857407 doi: 10.1126/science.abd4570
Kosmicki, J. A. et al. Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individuals. Am. J. Hum. Genet. 108, 1350–1355 (2021).
pubmed: 34115965 doi: 10.1016/j.ajhg.2021.05.017
Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273 (2020).
pubmed: 32015507 pmcid: 7095418 doi: 10.1038/s41586-020-2012-7
Pawitan, Y., Seng, K. C. & Magnusson, P. K. E. How many genetic variants remain to be discovered? PLoS ONE 4, e7969 (2009).
pubmed: 19956539 pmcid: 2780697 doi: 10.1371/journal.pone.0007969
Aguet, F. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science 369, 1318–1330 (2020).
doi: 10.1126/science.aaz1776
Keidar, S., Kaplan, M. & Gamliel-Lazarovich, A. ACE2 of the heart: from angiotensin I to angiotensin (1–7). Cardiovasc. Res. 73, 463–469 (2007).
pubmed: 17049503 doi: 10.1016/j.cardiores.2006.09.006
Backman, J. D. et al. Exome sequencing and analysis of 454,787 UK Biobank participants. Nature 599, 628–634 (2021).
pubmed: 34662886 pmcid: 8596853 doi: 10.1038/s41586-021-04103-z
Saheb Sharif-Askari, N. et al. Airways expression of SARS-CoV-2 receptor, ACE2, and TMPRSS2 is lower in children than adults and increases with smoking and COPD. Mol. Ther. Methods Clin. Dev. 18, 1–6 (2020).
pubmed: 32537478 pmcid: 7242205 doi: 10.1016/j.omtm.2020.05.013
Bunyavanich, S., Do, A. & Vicencio, A. Nasal gene expression of angiotensin-converting enzyme 2 in children and adults. JAMA 323, 2427–2429 (2020).
pubmed: 32432657 pmcid: 7240631 doi: 10.1001/jama.2020.8707
Zeberg, H. & Pääbo, S. The major genetic risk factor for severe COVID-19 is inherited from Neanderthals. Nature 587, 610–612 (2020).
pubmed: 32998156 doi: 10.1038/s41586-020-2818-3
Hadjadj, J. et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369, 718–724 (2020).
pubmed: 32661059 pmcid: 7402632 doi: 10.1126/science.abc6027
Ling, Y. H. et al. CCHCR1 interacts with EDC4, suggesting its localization in P-bodies. Exp. Cell Res. 327, 12–23 (2014).
pubmed: 24858563 doi: 10.1016/j.yexcr.2014.05.008
Tervaniemi, M. H. et al. Intracellular signalling pathways and cytoskeletal functions converge on the psoriasis candidate gene CCHCR1 expressed at P-bodies and centrosomes. BMC Genomics 19, 432 (2018).
pubmed: 29866042 pmcid: 5987482 doi: 10.1186/s12864-018-4810-y
Kim, Y. J. et al. A genome-wide association study identified new variants associated with the risk of chronic hepatitis B. Hum. Mol. Genet. 22, 4233–4238 (2013).
pubmed: 23760081 doi: 10.1093/hmg/ddt266
Vuille-dit-Bille, R. N. et al. Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors. Amino Acids 47, 693–705 (2015).
pubmed: 25534429 doi: 10.1007/s00726-014-1889-6
Cui, Y. et al. SENP7 potentiates cGAS activation by relieving SUMO-mediated inhibition of cytosolic DNA sensing. PLoS Pathog. 13, e1006156 (2017).
pubmed: 28095500 pmcid: 5271409 doi: 10.1371/journal.ppat.1006156
Rollinger-Holzinger, I. et al. LST1: a gene with extensive alternative splicing and immunomodulatory function. J. Immunol. 164, 3169–3176 (2000).
pubmed: 10706707 doi: 10.4049/jimmunol.164.6.3169
Mulcahy, H., O’Rourke, K. P., Adams, C., Molloy, M. G. & O’Gara, F. LST1 and NCR3 expression in autoimmune inflammation and in response to IFN-γ, LPS and microbial infection. Immunogenetics 57, 893–903 (2006).
pubmed: 16362817 doi: 10.1007/s00251-005-0057-2
Apps, R. et al. Influence of HLA-C expression level on HIV control. Science 340, 87–91 (2013).
pubmed: 23559252 pmcid: 3784322 doi: 10.1126/science.1232685
Kulkarni, S. et al. Genetic interplay between HLA-C and MIR148A in HIV control and Crohn disease. Proc. Natl Acad. Sci. USA 110, 20705–20710 (2013).
pubmed: 24248364 pmcid: 3870724 doi: 10.1073/pnas.1312237110
Begue, B. et al. Defective IL10 signaling defining a subgroup of patients with inflammatory bowel disease. Am. J. Gastroenterol. 106, 1544–1555 (2011).
pubmed: 21519361 doi: 10.1038/ajg.2011.112
Frodsham, A. J. et al. Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence. Proc. Natl Acad. Sci. USA 103, 9148–9153 (2006).
pubmed: 16757563 pmcid: 1482581 doi: 10.1073/pnas.0602800103
Qi, T. et al. Identifying gene targets for brain-related traits using transcriptomic and methylomic data from blood. Nat. Commun. 9, 2282 (2018).
pubmed: 29891976 pmcid: 5995828 doi: 10.1038/s41467-018-04558-1
Mbatchou, J. et al. Computationally efficient whole-genome regression for quantitative and binary traits. Nat. Genet. 53, 1097–1103 (2021).
pubmed: 34017140 doi: 10.1038/s41588-021-00870-7
Roberts, G. H. L. et al. AncestryDNA COVID-19 host genetic study identifies three novel loci. Preprint at medRxiv https://doi.org/10.1101/2020.10.06.20205864 (2020).
Dewey, F. E. et al. Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study. Science 354, aaf6814 (2016).
pubmed: 28008009 doi: 10.1126/science.aaf6814
Park, J. et al. A genome-first approach to aggregating rare genetic variants in LMNA for association with electronic health record phenotypes. Genet. Med. 22, 102–111 (2020).
pubmed: 31383942 doi: 10.1038/s41436-019-0625-8
Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203–209 (2018).
pubmed: 30305743 pmcid: 6786975 doi: 10.1038/s41586-018-0579-z
Morales, J. et al. A standardized framework for representation of ancestry data in genomics studies, with application to the NHGRI-EBI GWAS Catalog. Genome Biol. 19, 21 (2018).
pubmed: 29448949 pmcid: 5815218 doi: 10.1186/s13059-018-1396-2
Ferreira, M. A. et al. Shared genetic origin of asthma, hay fever and eczema elucidates allergic disease biology. Nat. Genet. 49, 1752–1757 (2017).
pubmed: 29083406 pmcid: 5989923 doi: 10.1038/ng.3985
Chun, S. et al. Limited statistical evidence for shared genetic effects of eQTLs and autoimmune-disease-associated loci in three major immune-cell types. Nat. Genet. 49, 600–605 (2017).
pubmed: 28218759 pmcid: 5374036 doi: 10.1038/ng.3795
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
pubmed: 23104886 doi: 10.1093/bioinformatics/bts635
Robinson, M. D. & Oshlack, A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 11, R25 (2010).
pubmed: 20196867 pmcid: 2864565 doi: 10.1186/gb-2010-11-3-r25
Vilhjálmsson, B. J. et al. Modeling linkage disequilibrium increases accuracy of polygenic risk scores. Am. J. Hum. Genet. 97, 576–592 (2015).
pubmed: 26430803 pmcid: 4596916 doi: 10.1016/j.ajhg.2015.09.001

Auteurs

Julie E Horowitz (JE)

Regeneron Genetics Center, Tarrytown, NY, USA.

Jack A Kosmicki (JA)

Regeneron Genetics Center, Tarrytown, NY, USA.

Amy Damask (A)

Regeneron Genetics Center, Tarrytown, NY, USA.

Deepika Sharma (D)

Regeneron Genetics Center, Tarrytown, NY, USA.

Anne E Justice (AE)

Geisinger, Danville, PA, USA.

Nilanjana Banerjee (N)

Regeneron Genetics Center, Tarrytown, NY, USA.

Marie V Coignet (MV)

AncestryDNA, Lehi, UT, USA.

Ashish Yadav (A)

Regeneron Genetics Center, Tarrytown, NY, USA.

Anthony Marcketta (A)

Regeneron Genetics Center, Tarrytown, NY, USA.

Danny S Park (DS)

AncestryDNA, Lehi, UT, USA.

Rouel Lanche (R)

Regeneron Genetics Center, Tarrytown, NY, USA.

Evan Maxwell (E)

Regeneron Genetics Center, Tarrytown, NY, USA.

Spencer C Knight (SC)

AncestryDNA, Lehi, UT, USA.

Xiaodong Bai (X)

Regeneron Genetics Center, Tarrytown, NY, USA.

Harendra Guturu (H)

AncestryDNA, Lehi, UT, USA.

Dylan Sun (D)

Regeneron Genetics Center, Tarrytown, NY, USA.

Asher Baltzell (A)

AncestryDNA, Lehi, UT, USA.

Fabricio S P Kury (FSP)

Regeneron Genetics Center, Tarrytown, NY, USA.

Joshua D Backman (JD)

Regeneron Genetics Center, Tarrytown, NY, USA.

Ahna R Girshick (AR)

AncestryDNA, Lehi, UT, USA.

Colm O'Dushlaine (C)

Regeneron Genetics Center, Tarrytown, NY, USA.

Shannon R McCurdy (SR)

AncestryDNA, Lehi, UT, USA.

Raghavendran Partha (R)

AncestryDNA, Lehi, UT, USA.

Adam J Mansfield (AJ)

Regeneron Genetics Center, Tarrytown, NY, USA.

David A Turissini (DA)

AncestryDNA, Lehi, UT, USA.

Alexander H Li (AH)

Regeneron Genetics Center, Tarrytown, NY, USA.

Miao Zhang (M)

AncestryDNA, Lehi, UT, USA.

Joelle Mbatchou (J)

Regeneron Genetics Center, Tarrytown, NY, USA.

Kyoko Watanabe (K)

Regeneron Genetics Center, Tarrytown, NY, USA.

Lauren Gurski (L)

Regeneron Genetics Center, Tarrytown, NY, USA.

Shane E McCarthy (SE)

Regeneron Genetics Center, Tarrytown, NY, USA.

Hyun M Kang (HM)

Regeneron Genetics Center, Tarrytown, NY, USA.

Lee Dobbyn (L)

Regeneron Genetics Center, Tarrytown, NY, USA.

Eli Stahl (E)

Regeneron Genetics Center, Tarrytown, NY, USA.

Anurag Verma (A)

Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Giorgio Sirugo (G)

Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Marylyn D Ritchie (MD)

Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Marcus Jones (M)

Regeneron Genetics Center, Tarrytown, NY, USA.

Suganthi Balasubramanian (S)

Regeneron Genetics Center, Tarrytown, NY, USA.

Katherine Siminovitch (K)

Regeneron Genetics Center, Tarrytown, NY, USA.

William J Salerno (WJ)

Regeneron Genetics Center, Tarrytown, NY, USA.

Alan R Shuldiner (AR)

Regeneron Genetics Center, Tarrytown, NY, USA.

Daniel J Rader (DJ)

Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Adam E Locke (AE)

Regeneron Genetics Center, Tarrytown, NY, USA.

Jonathan Marchini (J)

Regeneron Genetics Center, Tarrytown, NY, USA.

John D Overton (JD)

Regeneron Genetics Center, Tarrytown, NY, USA.

David J Carey (DJ)

Geisinger, Danville, PA, USA.

Lukas Habegger (L)

Regeneron Genetics Center, Tarrytown, NY, USA.

Michael N Cantor (MN)

Regeneron Genetics Center, Tarrytown, NY, USA.

Kristin A Rand (KA)

AncestryDNA, Lehi, UT, USA.

Eurie L Hong (EL)

AncestryDNA, Lehi, UT, USA.

Jeffrey G Reid (JG)

Regeneron Genetics Center, Tarrytown, NY, USA.

Catherine A Ball (CA)

AncestryDNA, Lehi, UT, USA.

Aris Baras (A)

Regeneron Genetics Center, Tarrytown, NY, USA.

Gonçalo R Abecasis (GR)

Regeneron Genetics Center, Tarrytown, NY, USA.

Manuel A R Ferreira (MAR)

Regeneron Genetics Center, Tarrytown, NY, USA. manuel.ferreira@regeneron.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH